We also evaluated the potential correlation of KCNH2 expression with 60 immune checkpoints and showed that KCNH2 was positively correlated with most immune checkpoints across cancers, especially THCA, UVM, and PRAD (Fig. 9). The gene discussed is KCNH2; the disease is cancer.